Advertisement
CBLL vs PMI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBLL is a StrongBuy and PMI is a Hold.
CBLL's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for CBLL turned positive on October 13, 2026. Looking at past instances where CBLL's MACD turned positive, the stock continued to rise in 10 of 10 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on CBLL as a result. In 22 of 27 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
Following a +10.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBLL advanced for three days, in 95 of 111 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Aroon Indicator entered an Uptrend today. In 40 of 54 cases where CBLL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Bearish Trend Analysis
The 10-day RSI Indicator for CBLL moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In 10 of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBLL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
CBLL broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.120) is normal, around the industry mean (2.923). P/E Ratio (-15.420) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (9.009) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CBLL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBLL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
PMI's RSI Oscillator leaves overbought zone
The 10-day RSI Oscillator for PMI moved out of overbought territory on October 20, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 3 instances where the indicator moved out of the overbought zone. In 3 of the 3 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 4 of 4 cases where PMI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
PMI broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on PMI as a result. In 8 of 12 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for PMI just turned positive on October 02, 2026. Looking at past instances where PMI's MACD turned positive, the stock continued to rise in 5 of 6 cases over the following month. The odds of a continued upward trend are 83%.
PMI moved above its 50-day moving average on October 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PMI crossed bullishly above the 50-day moving average on October 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 1 of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +54.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where PMI advanced for three days, in 32 of 39 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 10 of 12 cases where PMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 83%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. PMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.124) is normal, around the industry mean (2.923). P/E Ratio (-0.269) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (2.114) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
| CBLL | PMI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 81% | 2 days ago 67% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 73% | 2 days ago 88% |
| Advances ODDS (%) | 3 days ago 86% | 4 days ago 82% |
| Declines ODDS (%) | 15 days ago 77% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 73% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 74% | 2 days ago 83% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CBLL’s FA Score shows that 1 FA rating(s) are green while PMI’s FA Score has 0 green FA rating(s).
- CBLL’s FA Score: 1 green, 4 red.
- PMI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CBLL’s TA Score shows that 4 TA indicator(s) are bullish while PMI’s TA Score has 6 bullish TA indicator(s).
- CBLL’s TA Score: 4 bullish, 4 bearish.
- PMI’s TA Score: 6 bullish, 4 bearish.
Price Growth
CBLL (@Medical/Nursing Services) experienced а +2.92% price change this week, while PMI (@Medical/Nursing Services) price change was -24.05% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.59%. For the same industry, the average monthly price growth was -10.79%, and the average quarterly price growth was -10.52%.
Reported Earning Dates
CBLL is expected to report earnings on Nov 03, 2026.
PMI is expected to report earnings on Nov 13, 2026.
Industries' Descriptions
@Medical/Nursing Services (-1.59% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
CBLL and
Correlation & Price change
A.I.dvisor indicates that over the last year, CBLL has been loosely correlated with NPCE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CBLL jumps, then NPCE could also see price increases.
| Ticker / NAME | Correlation To CBLL | 1D Price Change % | ||
|---|---|---|---|---|
| CBLL | 100% | -1.95% | ||
| NPCE - CBLL | 39% Loosely correlated | -3.40% | ||
| BFLY - CBLL | 37% Loosely correlated | -2.87% | ||
| KIDS - CBLL | 35% Loosely correlated | +1.45% | ||
| IART - CBLL | 33% Loosely correlated | -11.18% | ||
| CERS - CBLL | 32% Poorly correlated | +3.46% | ||
More | ||||
PMI and
Correlation & Price change
A.I.dvisor tells us that PMI and AVR have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PMI and AVR's prices will move in lockstep.
| Ticker / NAME | Correlation To PMI | 1D Price Change % | ||
|---|---|---|---|---|
| PMI | 100% | -8.11% | ||
| AVR - PMI | 19% Poorly correlated | -4.45% | ||
| BFLY - PMI | 10% Poorly correlated | -2.87% | ||
| CBLL - PMI | 8% Poorly correlated | -1.95% | ||
| RXST - PMI | 6% Poorly correlated | +0.41% | ||
| XTNT - PMI | 6% Poorly correlated | -2.31% | ||
More | ||||